Advances in non-covalent based inhibitors targeting Myc: a promising approach for cancer treatment

Future Med Chem. 2024 Jan;16(2):101-103. doi: 10.4155/fmc-2023-0332. Epub 2023 Dec 12.

Authors

Vipendra Kumar Singh¹, Naina Rajak², Rajanish Giri¹, Neha Garg²

Affiliations

¹ School of Biosciences & Bioengineering, Indian Institute of Technology Mandi, VPO Kamand, Mandi-175075, HP, India.
² Faculty of Ayurveda, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

PMID: 38084612
DOI: 10.4155/fmc-2023-0332

No abstract available

Keywords: Myc protein; cancers; non-covalent inhibitors; oncogene; undruggable.

Publication types

Editorial

MeSH terms

Antineoplastic Agents* / pharmacology
Antineoplastic Agents* / therapeutic use
Humans
Neoplasms* / drug therapy
Proto-Oncogene Proteins c-myc

Substances

Antineoplastic Agents
Proto-Oncogene Proteins c-myc